For nearly a century, the Tasmanian tiger, or thylacine, has been considered lost to history—a victim of hunting, habitat destruction, and government policies that wiped out Australia’s last marsupial ...

As unbelievable as it may seem, woolly mammoths are potentially returning to our planet. According to an article from The ...

We will discover new tools, new ways that we can help species that are still alive but in danger of becoming extinct.” ...

Colossal Biosciences cofounder and CEO Ben Lamm is worth $3.7 billion following the company's recent fundraise at an eye-popping $10.2 billion valuation. But it has yet to be paid for reviving extinct ...

Scientists recovered RNA from a 110-year-old Tasmanian tiger head, advancing gene editing and de-extinction efforts to bring back the lost predator within years.

Colossal Biosciences, a Dallas-based biotechnology and genetic engineering startup valued at $10 billion, has raised $435 ...

Colossal Biosciences has focused on identifying key traits of extinct animals by studying ancient DNA, with a goal to genetically "engineer them into living animals," said CEO Ben Lamm.

Once considered a lost species, this carnivorous marsupial, officially known as the thylacine, could soon make a comeback thanks to groundbreaking advancements in genetics. Using advanced ...

Scientists have taken another step towards the resurrection of the Tasmanian tiger with the first successful recovery of RNA from an extinct species. RNA is the genetic material present in all ...

A team of scientists from Australia and the US say they've had an exciting breakthrough in trying to bring back the Tasmanian tiger from extinction. The tiger, also known as Thylacine, was a wolf ...

The CEO of Colossal, a startup that aims to use genetic editing techniques to bring back extinct species, including the wooly ...